Variation Biotechnologies Receives $1,500,000 New Funding Round

Share and Comment

2 Comments Order a Reprint E-mail this Story

• Share on Twitter
• Share on Facebook


• Share on Linkedin
• Share on Google
• Submit to Hacker News

• Feed Type
  
• Link
  http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c4a61a89-8aee-4e44-ab7d-5d59f54843d0
• Date
  3/27/2014
• Company Name
  Variation Biotechnologies
• Mailing Address
  222 Third Street Cambridge, MA 02142 USA
• Company Description
  Variation Biotechnologies, Inc. (VBI) creates intelligent vaccines that learn from nature. Our management and scientific team consists of industry-leading experts that have increased our product pipeline and partnerships.
• Website
  http://www.variationbiotech.com
• Transaction Type
  Debt
• Transaction Amount
  $1,500,000
• Transaction Round
  Undisclosed
• Proceeds Purposes
  Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
• M&A Terms
  
• Venture Investor
  

• Share on Facebook
• Share on Twitter
• LinkedIn
• Email
• Reprints

Trending on Xconomy

• Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO
• Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs
• ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More

By posting a comment, you agree to our terms and conditions.

2 responses to “Variation Biotechnologies Receives $1,500,000 New Funding Round”

1. Pink says:

   April 4, 2014 at 5:02 pm

   How can they create intelligent vaccines when there is no single intelligent person in their management team!

2. Harris says:

   April 4, 2014 at 5:11 pm

   The company founded in 2001 and they have no commercial products yet! The CEO and rest of management team should be fired long time ago.